These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. Pu L; Bao GB; Xu NJ; Ma L; Pei G J Neurosci; 2002 Mar; 22(5):1914-21. PubMed ID: 11880521 [TBL] [Abstract][Full Text] [Related]
23. Potentiation of synaptic strength and intrinsic excitability in the nucleus accumbens after 10 days of morphine withdrawal. Wu X; Shi M; Wei C; Yang M; Liu Y; Liu Z; Zhang X; Ren W J Neurosci Res; 2012 Jun; 90(6):1270-83. PubMed ID: 22388870 [TBL] [Abstract][Full Text] [Related]
24. micro-Opioid receptor endocytosis prevents adaptations in ventral tegmental area GABA transmission induced during naloxone-precipitated morphine withdrawal. Madhavan A; He L; Stuber GD; Bonci A; Whistler JL J Neurosci; 2010 Mar; 30(9):3276-86. PubMed ID: 20203187 [TBL] [Abstract][Full Text] [Related]
25. Transgenic mice with cerebral expression of human immunodeficiency virus type-1 coat protein gp120 show divergent changes in short- and long-term potentiation in CA1 hippocampus. Krucker T; Toggas SM; Mucke L; Siggins GR Neuroscience; 1998 Apr; 83(3):691-700. PubMed ID: 9483553 [TBL] [Abstract][Full Text] [Related]
26. Hypothalamic orexin--a neurons are involved in the response of the brain stress system to morphine withdrawal. Laorden ML; Ferenczi S; Pintér-Kübler B; González-Martín LL; Lasheras MC; Kovács KJ; Milanés MV; Núñez C PLoS One; 2012; 7(5):e36871. PubMed ID: 22590628 [TBL] [Abstract][Full Text] [Related]
27. A central role for glial CCR5 in directing the neuropathological interactions of HIV-1 Tat and opiates. Kim S; Hahn YK; Podhaizer EM; McLane VD; Zou S; Hauser KF; Knapp PE J Neuroinflammation; 2018 Oct; 15(1):285. PubMed ID: 30305110 [TBL] [Abstract][Full Text] [Related]
28. Modulation of apoptosis in the mouse brain after morphine treatments and morphine withdrawal. Emeterio EP; Tramullas M; Hurlé MA J Neurosci Res; 2006 May; 83(7):1352-61. PubMed ID: 16496378 [TBL] [Abstract][Full Text] [Related]
30. Regional heterogeneity and diversity in cytokine and chemokine production by astroglia: differential responses to HIV-1 Tat, gp120, and morphine revealed by multiplex analysis. Fitting S; Zou S; Chen W; Vo P; Hauser KF; Knapp PE J Proteome Res; 2010 Apr; 9(4):1795-804. PubMed ID: 20121167 [TBL] [Abstract][Full Text] [Related]
31. Regulation of dopaminergic markers expression in response to acute and chronic morphine and to morphine withdrawal. García-Pérez D; Núñez C; Laorden ML; Milanés MV Addict Biol; 2016 Mar; 21(2):374-86. PubMed ID: 25522207 [TBL] [Abstract][Full Text] [Related]
32. ¹H NMR-based metabonomic analysis of brain in rats of morphine dependence and withdrawal intervention. Hu Z; Deng Y; Hu C; Deng P; Bu Q; Yan G; Zhou J; Shao X; Zhao J; Li Y; Zhu R; Xu Y; Zhao Y; Cen X Behav Brain Res; 2012 May; 231(1):11-9. PubMed ID: 22391120 [TBL] [Abstract][Full Text] [Related]
33. Up-regulation of the p75 neurotrophin receptor is an essential mechanism for HIV-gp120 mediated synaptic loss in the striatum. Speidell A; Asuni GP; Wakulski R; Mocchetti I Brain Behav Immun; 2020 Oct; 89():371-379. PubMed ID: 32717404 [TBL] [Abstract][Full Text] [Related]
34. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. El-Hage N; Gurwell JA; Singh IN; Knapp PE; Nath A; Hauser KF Glia; 2005 Apr; 50(2):91-106. PubMed ID: 15630704 [TBL] [Abstract][Full Text] [Related]
35. Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neurons. Fitting S; Xu R; Bull C; Buch SK; El-Hage N; Nath A; Knapp PE; Hauser KF Am J Pathol; 2010 Sep; 177(3):1397-410. PubMed ID: 20651230 [TBL] [Abstract][Full Text] [Related]
36. Regulation of G protein-coupled receptor kinase 2 in brains of opiate-treated rats and human opiate addicts. Ozaita A; Escribá PV; Ventayol P; Murga C; Mayor F; García-Sevilla JA J Neurochem; 1998 Mar; 70(3):1249-57. PubMed ID: 9489748 [TBL] [Abstract][Full Text] [Related]
37. Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption. Walters CL; Wang BC; Godfrey M; Sun D; Funk CD; Blendy JA Psychopharmacology (Berl); 2003 Nov; 170(2):124-31. PubMed ID: 12845410 [TBL] [Abstract][Full Text] [Related]
38. Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120. Roberts AJ; Maung R; Sejbuk NE; Ake C; Kaul M J Neurosci Methods; 2010 Feb; 186(2):222-5. PubMed ID: 19917310 [TBL] [Abstract][Full Text] [Related]
39. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine. Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477 [TBL] [Abstract][Full Text] [Related]
40. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal. Asensio VJ; Miralles A; García-Sevilla JA Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]